MedPath

Effect of Phalatrikadi Ghanavati in Cholesterol Disorder

Phase 2
Conditions
Health Condition 1: null- Diabetic Dyslipidemia
Registration Number
CTRI/2018/04/013099
Lead Sponsor
ational Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients willing to sign the consent form.

2. Patients between the age group of 20-60 years of either sex.

3. Diagnosed and confirmed cases of Dyslipidemia in Diabetes Mellitus Type II patients (based on NCEP-Adult treatment panel III guideline) Total Cholesterol (TC) > 200 mg/dl, Triglyceride (TG) > 150 mg/dl, Low Density Lipoprotein (LDL) > 130 mg/dl, High Density Lipoprotein (HDL) < 40 mg/dl, Fasting blood sugar (FBS) <140 mg/dl, Post Prandial blood sugar (PPBS) < 200 mg/dl.

Exclusion Criteria

1. Patients having Type - DM I [IDDM]

2. Patient of type II DM who are on Insulin therapy.

3. DM with Coronary Artery Diseases (CAD), Malignancy or any other serious illness.

4. DM with serious complications.

5. Diabetes Insipidus.

6. Drug induced DM.

7. Fasting Blood Sugar >140mg/dl.

8. Postprandial Blood Sugar >200mg/dl.

9. Uncontrolled Hypertension (systolic blood pressure >150 mm of Hg and /or Diastolic blood pressure >100 mm of Hg).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath